PWM
XFOR icon

Palumbo Wealth Management’s X4 Pharmaceuticals XFOR Stock Holding History

Palumbo Wealth Management’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$313K Sell
67,116
-63,898
-49% -$262K 0.07% 185
2026
Q1 		$541K Buy
131,014
+17,657
+16% +$66.1K 0.13% 118
2025
Q4 		$453K Buy
113,357
+18,030
+19% +$65.5K 0.11% 133
2025
Q3 		$326K Buy
+95,327
New +$246K 0.1% 122

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Palumbo Wealth Management's XFOR Position: Q2 2026 in Review

Palumbo Wealth Management reduced its X4 Pharmaceuticals (XFOR) stake by 49% in Q2 2026, selling an estimated $262K and leaving 67,116 shares worth $313K. The position accounts for 0.07% of the portfolio, ranked #185.

Palumbo Wealth Management first reported a position in XFOR in Q3 2025 and has held it in 4 quarters since. The position peaked at $541K in Q1 2026. 89 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

  • Palumbo Wealth Management held 67,116 shares of X4 Pharmaceuticals worth $313K as of Q2 2026.
  • Palumbo Wealth Management sold 63,898 X4 Pharmaceuticals shares in Q2 2026, an estimated $262K.
  • X4 Pharmaceuticals made up 0.07% of Palumbo Wealth Management's portfolio in Q2 2026, its #185 holding.
  • Palumbo Wealth Management first reported a position in X4 Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Palumbo Wealth Management's X4 Pharmaceuticals position peaked at $541K in Q1 2026.
  • 89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on Palumbo Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.